[1]
“The study of Pharmacoeconomics analysis on anti tuberculosis drugs Rifampicin & Ethambutol”, Int. J. Res. Clin. Hosp. Pharm., vol. 1, no. 1, pp. 31–40, Mar. 2024, Accessed: May 25, 2026. [Online]. Available: https://rubatosisjournals.com/index.php/ijrhcp/article/view/311